Abstract
This chapter of clinical neuroradiology focuses on the use of skeletal muscle imaging in dystrophic myopathies. It will discuss the use of both conventional (computed tomography, magnetic resonance imaging, ultrasound) and advanced muscle radiological techniques (diffusion tensor imaging, MR spectroscopy) to visualize the extent and distribution of muscle tissue damage which can be seen in this group of disorders. Muscle imaging can help to differentiate between different dystrophic myopathies and can be used as an aid for guided muscle biopsy. Indications for imaging will be discussed, and recommendations on systematically visualizing and evaluating the skeletal muscles will be formulated. Standardization of imaging tools is required before they can be used as reliable surrogate biomarkers in natural history studies and in therapeutic trials.
This publication is endorsed by: European Society of Neuroradiology (www.esnr.org)
Parts of this chapter have been reproduced from ten Dam, L., van der Kooi, A. J., Verhamme, C., Wattjes, M. P. and de Visser, M. (2016), Muscle imaging in inherited and acquired muscle diseases. Eur J Neurol, 23: 688–703 with permission from Wiley publications.
Abbreviations
- BMD:
-
Becker muscular dystrophy
- CMD:
-
Congenital muscular dystrophy
- DM1:
-
Myotonic dystrophy type 1
- DM2:
-
Myotonic dystrophy type 2
- DMD:
-
Duchenne muscular dystrophy
- FSHD:
-
Facioscapulohumeral dystrophy
- LGMD:
-
Limb-girdle muscular dystrophy
- MMD:
-
Miyoshi distal myopathy
- OPMD:
-
Oculopharyngeal muscular dystrophy
- TMD:
-
Tibial muscular dystrophy/Udd myopathy
- UCMD:
-
Ullrich congenital muscular dystrophy
- WMD:
-
Welander distal myopathy
References
Andersen G, Dahlqvist JR, Vissing CR. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients. J Neurol. 2017;264: 483–47.
Arpan I, Willcocks RJ, Forbes SC, et al. Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology. 2014;83: 974–80.
Bönnemann CG, Wang CH, Quijano-Roy S. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24:289–311.
Burakiewicz J, Sinclair CDJ, Fischer D. Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy. J Neurol. 2017;264:2053–67.
Carboni N, Mura M, Marrosu G, et al. Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. Muscle Nerve. 2010;41:458–63.
Dahlqvist JR, Vissing CR, Thomsen C, et al. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy. Neurology. 2014;83:1178–83.
Drakonaki EE, Allen GM. Magnetic resonance imaging, ultrasound and real-time ultrasound elastography of the thigh muscles in congenital muscle dystrophy. Skelet Radiol. 2010;39:391–6.
Fatehi F, Salort-Campana E, Le Troter A, et al. Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: a quantitative study. PLoS One. 2017;12:e0183825.
Fischer D, Bonati U, Wattjes MP. Recent developments in muscle imaging of neuromuscular disorders. Curr Opin Neurol. 2016;29:614–20.
Fischmann A, Gloor M, Fasler S, et al. Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy. J Neurol. 2011;258:1333–40.
Fischmann A, Hafner P, Fasler S, et al. Quantitative MRI can detect subclinical disease progression in muscular dystrophy. J Neurol. 2012;259:1648–54.
Fischmann A, Morrow JM, Sinclair CD, et al. Improved anatomical reproducibility in quantitative lower-limb muscle MRI. J Magn Reson Imaging. 2014;39:1033–8.
Fleckenstein JL, Watumull D, Conner KE, et al. Denervated human skeletal muscle: MR imaging evaluation. Radiology. 1993;187:213–8.
Franc DT, Muetzel RL, Robinson PR, et al. Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord. 2012;22:483–91.
Gómez-Andres D, Dabai I, Monpoint D. Pediatric laminopathies: whole-body magnetic resonance imaging fingerprint and comparison with Sepn1 myopathy. Muscle Nerve. 2016;54:192–202.
Hafner P, Bonati U, Fischmann A, et al. Skeletal muscle MRI of the lower limbs in congenital muscular dystrophy patients with novel POMT1 and POMT2 mutations. Neuromuscul Disord. 2014;2014:321–4.
Hicks D, Sarkozy A, Muelas N, et al. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy. Brain. 2011;134:171–82.
Hollingsworth KG, de Sousa PL, Straub V, et al. Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations for two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris, France. Neuromuscul Disord. 2012;22:S54–67.
Janssen BH, Pillen S, Voet NB, et al. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy. Muscle Nerve. 2014a;50:968–75.
Janssen BH, Voet NB, Nabuurs CI, et al. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration. PLoS One. 2014b;9:e85416.
Joyce NC, Oskarsson B, Jin LW. Muscle biopsy evaluation in neuromuscular disorders. Physical medicine and rehabilitation clinics of North America. 2012;23(3):609–31.
Kornblum C, Lutterbey G, Bogdanow M, et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2. J Neurol. 2006;253:753–61.
Laroche M, Cintas P. Bent spine syndrome (camptocormia): a retrospective study of 63 patients. Joint Bone Spine. 2010;77:593–6.
Leung DG. Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review. J Neurol. 2017;264:1320–33.
Leung DG, Carrino JA, Wagner KR, et al. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy. Muscle Nerve. 2015;52:512–20.
Li GD, Liang YY, Xu P. Diffusion-tensor imaging of thigh muscles in Duchenne muscular dystrophy: correlation of apparent diffusion coefficient and fractional anisotropy values with fatty infiltration. Am J Roentgenol. 2016;206:867–70.
Liewluck T, Winder TL, Dimberg EL, et al. ANO5-muscular dystrophy: clinical, pathological and molecular findings. Eur J Neurol. 2013;20:1383–9.
Mercuri E, Cini C, Counsell S, et al. Muscle MRI findings in a three-generation family affected by Bethlem myopathy. Eur J Paediatr Neurol. 2002a;6:309–14.
Mercuri E, Counsell S, Allsop J, et al. Selective muscle involvement on magnetic-resonance imaging in autosomal dominant Emery-Dreifuss muscular dystrophy. Neuropediatrics. 2002b;33:10–4.
Mercuri E, Lampe A, Allsop J, et al. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord. 2005;15:303–10.
Mercuri E, Pichiecchio A, Allsop J, et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging. 2007;25:433–40.
Mercuri E, Clements E, Offiah A, et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol. 2010;67:201–8.
Morrow JM, Matthews E, Raja Rayan DL, et al. Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscul Disord. 2013;23:637–46.
Paradas C, Llauger J, Diaz-Manera J, et al. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology. 2010;75: 316–23.
Pillen S, van Alfen N, Zwarts MJ. Ultrasound of muscle. In: Walker F, Cartwright MS, editors. Neuromuscular ultrasound. 1st ed. Philadelphia: Elsevier; 2011. p. 37–56.
Quijano-Roy S, Avila-Smirnow D, Carlier RY, et al. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Neuromuscul Disord. 2012;22:S68–84.
Rijken NH, van der Kooi EL, Hendriks JC, et al. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement. Neuromuscul Disord. 2014;24:1087–96.
Schedel H, Reimers CD, Vogl T, et al. Muscle edema in MR imaging of neuromuscular diseases. Acta Radiol. 1995;36:228–32.
Shkylar I, Geisbush TR, Mijialovic AS, et al. Quantitative muscle ultrasound in Duchenne muscular dystrophy: a comparison of techniques. Muscle Nerve. 2015;51: 207–13.
Straub V, Carlier PG, Mercuri E. Treat-NMD workshop: pattern recognition in genetic muscle disease using MRI: 25-26 February 2011, Rome, Italy. Neuromuscul Disord. 2012;22:S42–53.
Tasca G, Monforte M, Iannaccone E. Muscle MRI in Becker muscular dystrophy. Neuromuscul Disord. 2012a;22(Suppl 2):S100–6.
Tasca G, Monforte M, Iannaccone E. Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol. 2012b;19:1256–60.
ten Dam L, van der Kooi AJ, van Wattingen M, et al. Reliability and accuracy of muscle imaging in limb-girdle muscular dystrophies. Neurology. 2012;79:1716–23.
ten Dam L, van der Kooi AJ, Rövekamp F, et al. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies. Neuromuscul Disord. 2014;24:1097–102.
ten Dam L, van der Kooi AJ, Verhamme C, de Visser M. Muscle imaging in inherited and acquired muscle diseases. Eur J Neurol. 2016;23:688–703.
Udd B. Distal myopathies. Curr Neurol Neurosci Rep. 2014;14:434.
Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol. 2010;20:2447–60.
Willis TA, Hollingsworth KG, Coombs A, et al. Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study. PLoS One. 2014;9:e90377.
Wokke BH, Hooijmans MT, van den Bergen JC, et al. Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy. NMR Biomed. 2014;27:1371–7.
Wren T, Bluml S, Tseng-Ong L, et al. Three point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. Am J Roentgenol. 2008;190:W12.
Zaidman CM, Malkus EC, Connolly AM. Muscle ultrasound quantifies disease progression over time in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve. 2015;52:334–8.
Suggested Reading
Bönnemann CG, Wang CH, Quijano-Roy S, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24(4):289–311.
Burakiewicz J, Sinclair CDJ, Fischer D, et al. Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy. J Neurol. 2017;264:2053–67.
Fischer D, Bonati U, Wattjes MP. Recent developments in muscle imaging of neuromuscular disorders. Curr Opin Neurol. 2016;29(5):614–20.
Leung DG. Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review. J Neurol. 2017;264:1320–33.
Myo-MRI.eu
Neuromuscular.wustl.edu
Pillen S, van Alfen N. Skeletal muscle ultrasound. Neurol Res. 2011;33(10):1016–24.
Quijano-Roy S, Avila-Smirnow D, Carlier RY, et al. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Neuromuscul Disord. 2012;22(Suppl 2):S68–84.
Wattjes MP, Fischer D. Neuromuscular imaging. Berlin: Springer; 2013.
Udd B. Distal myopathies. Curr Neurol Neurosci Rep. 2014;14(3):434.
Acknowledgements
We would like to thank Prof. E. Aronica, Dr. W.C.G. Plandsoen, Dr. C. Verhamme and Dr. A.J. van der for providing figures 2, 6, 7 and 11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
ten Dam, L., de Visser, M. (2018). Dystrophic Myopathies. In: Barkhof, F., Jager, R., Thurnher, M., Rovira Cañellas, A. (eds) Clinical Neuroradiology. Springer, Cham. https://doi.org/10.1007/978-3-319-61423-6_3-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-61423-6_3-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61423-6
Online ISBN: 978-3-319-61423-6
eBook Packages: Springer Reference MedicineReference Module Medicine